Literature DB >> 16123158

Tau is hyperphosphorylated in the insulin-like growth factor-I null brain.

Clara M Cheng1, Victor Tseng, Jie Wang, Daniel Wang, Ludmila Matyakhina, Carolyn A Bondy.   

Abstract

IGF action has been implicated in the promotion of oxidative stress and aging in invertebrate and murine models. However, some in vitro models suggest that IGF-I specifically prevents neuronal oxidative damage. To investigate whether IGF-I promotes or retards brain aging, we evaluated signs of oxidative stress and neuropathological aging in brains from 400-d-old Igf1-/- and wild-type (WT) mice. Lipofuscin pigment accumulation reflects oxidative stress and aging, but we found no difference in lipofuscin deposition in Igf1-/- and WT brains. Likewise, there was no apparent difference in accumulation of nitrotyrosine residues in Igf1-/- and WT brains, except for layer IV/V of the cerebral cortex, where these proteins were about 20% higher in the Igf1-/- brain (P = 0.03). We found no difference in the levels of oxidative stress-related enzymes, neuronal nitric oxide synthase, inducible nitric oxide synthase, and superoxide dismutase in Igf1-/- and WT brains. Tau is a microtubule-associated protein that causes the formation of neurofibrillary tangles and senile plaques as it becomes hyperphosphorylated in the aging brain. Tau phosphorylation was dramatically increased on two specific residues, Ser-396 and Ser-202, both glycogen synthase kinases target sites implicated in neurodegeneration. These observations indicate that IGF-I has a major role in regulating tau phosphorylation in the aging brain, whereas its role in promoting or preventing oxidative stress remains uncertain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123158     DOI: 10.1210/en.2005-0063

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

Review 1.  The association of diabetes and dementia and possible implications for nondiabetic populations.

Authors:  Ramit Ravona-Springer; Michal Schnaider-Beeri
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

Review 2.  Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

Authors:  Sónia C Correia; Renato X Santos; George Perry; Xiongwei Zhu; Paula I Moreira; Mark A Smith
Journal:  Ageing Res Rev       Date:  2011-01-22       Impact factor: 10.895

3.  Estrogens need insulin-like growth factor I cooperation to exert their neuroprotective effects in post-menopausal women.

Authors:  M Giunta; A E Rigamonti; S M Bonomo; M G Gagliano; E E Müller; E Scarpini; D Galimberti; S G Cella
Journal:  J Endocrinol Invest       Date:  2012-03-22       Impact factor: 4.256

4.  MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1.

Authors:  Yi-Kui Hu; Xun Wang; Lian Li; Yan-Hua Du; Heng-Tai Ye; Cheng-Yan Li
Journal:  Neurosci Bull       Date:  2013-06-05       Impact factor: 5.203

Review 5.  Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.

Authors:  P Hemachandra Reddy
Journal:  Brain Res       Date:  2011-07-31       Impact factor: 3.252

Review 6.  How does diabetes accelerate Alzheimer disease pathology?

Authors:  Catrina Sims-Robinson; Bhumsoo Kim; Andrew Rosko; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2010-09-14       Impact factor: 42.937

Review 7.  Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer's disease neuropathology.

Authors:  James J Yang
Journal:  Acta Neurol Belg       Date:  2022-04-28       Impact factor: 2.471

8.  Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes.

Authors:  Bhumsoo Kim; Carey Backus; Sangsu Oh; John M Hayes; Eva L Feldman
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

9.  The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia.

Authors:  Lorna Moll; Markus Schubert
Journal:  Curr Gerontol Geriatr Res       Date:  2012-05-13

Review 10.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.